Please assess the completion status of the following clinical trial:

Trial Title: Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing pre-operative pelvic chemo-radiotherapy for histologically confirmed rectal adenocarcinoma, with the following staging: cT3N0-2, cT4N0-2, cT(any)N1-2, cT(any)N(any) CRM at-risk \[AJCC version V\]~* Staging / imaging of pelvis with MRI, and CT Thorax/Abdomen~* No evidence of metastatic disease~* ECOG Performance Status 0 - 2~* Age \> or equal to 18 years~* Provision of written informed consent in line with ICH-GCP guidelines~Exclusion Criteria:~* Previous radiotherapy to the pelvic region~* Patients in whom induction chemotherapy has been delivered prior to chemo- radiotherapy~* History of inflammatory bowel disease~* Previous hip replacement~* Previous bowel surgery (excluding procedures/operations which would not result in small bowel adhesions - at the discretion of the Principal Investigator)~* Patients with other syndromes/conditions associated with increased radiosensitivity~* Any other co-existing malignancies within the past 5 years other than non- melanoma skin cancer~* Pregnancy or lactation at the time of proposed randomisation~* Evidence of any other significant clinical disorder or laboratory finding that makes it undesirable for the patient to participate in the study or if it is felt by the research / medical team that the patient may not be able to comply with the protocol

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental Arm (Type: EXPERIMENTAL): 50.4 Gy / 28# external beam pelvic radiotherapy delivered using IMRT
- Control Arm (Type: NO_INTERVENTION): 50.4 Gy / 28# external beam pelvic radiotherapy delivered using a 3-Dimensional (3-D) planned technique

Based on this trial design, predict the completion outcome and termination type (if applicable).